SG11202109817VA - Novel bifidobacterium genus bacterium having high capacity to utilize polysaccharides of dietary origin - Google Patents

Novel bifidobacterium genus bacterium having high capacity to utilize polysaccharides of dietary origin

Info

Publication number
SG11202109817VA
SG11202109817VA SG11202109817VA SG11202109817VA SG 11202109817V A SG11202109817V A SG 11202109817VA SG 11202109817V A SG11202109817V A SG 11202109817VA SG 11202109817V A SG11202109817V A SG 11202109817VA
Authority
SG
Singapore
Prior art keywords
high capacity
genus bacterium
bifidobacterium genus
novel bifidobacterium
dietary origin
Prior art date
Application number
Inventor
Yohei Watanabe
Taeko Hara
Yoshimi Suzuki
Yuki Saito
Takahiro Matsuki
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Publication of SG11202109817VA publication Critical patent/SG11202109817VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477Hemicellulases not provided in a preceding group
    • C12N9/248Xylanases
    • C12N9/2482Endo-1,4-beta-xylanase (3.2.1.8)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01008Endo-1,4-beta-xylanase (3.2.1.8)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/535Pseudocatenulatum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG11202109817V 2019-03-29 2020-03-27 Novel bifidobacterium genus bacterium having high capacity to utilize polysaccharides of dietary origin SG11202109817VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019065395 2019-03-29
PCT/JP2020/014045 WO2020203782A1 (en) 2019-03-29 2020-03-27 Novel bifidobacterium genus bacterium having high capacity to utilize polysaccharides of dietary origin

Publications (1)

Publication Number Publication Date
SG11202109817VA true SG11202109817VA (en) 2021-10-28

Family

ID=72668403

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202109817V SG11202109817VA (en) 2019-03-29 2020-03-27 Novel bifidobacterium genus bacterium having high capacity to utilize polysaccharides of dietary origin

Country Status (12)

Country Link
US (1) US20220160795A1 (en)
EP (1) EP3949760A4 (en)
JP (1) JP7528057B2 (en)
KR (1) KR20210146295A (en)
CN (1) CN113613511A (en)
AU (1) AU2020251432A1 (en)
BR (1) BR112021019330A2 (en)
CA (1) CA3133958A1 (en)
MX (1) MX2021011930A (en)
SG (1) SG11202109817VA (en)
TW (1) TW202103583A (en)
WO (1) WO2020203782A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2023157860A1 (en) * 2022-02-17 2023-08-24
WO2024204682A1 (en) * 2023-03-31 2024-10-03 株式会社ヤクルト本社 Novel bacterium belonging to genus bifidobacterium

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3347163B2 (en) * 1992-06-18 2002-11-20 日清製粉株式会社 Useful intestinal bacteria growth promoter
US5405769A (en) * 1993-04-08 1995-04-11 National Research Council Of Canada Construction of thermostable mutants of a low molecular mass xylanase
JP3364491B2 (en) * 2002-07-25 2003-01-08 株式会社アトリエ・ド・フロマージュ Yogurt and method for producing the same
GB2412380B (en) * 2003-06-30 2005-11-09 Clasado Inc Novel galactooligosaccharide composition and the preparation thereof
EP2138186A1 (en) * 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and inflammation
CN101649303B (en) * 2009-05-08 2011-09-28 内蒙古蒙牛乳业(集团)股份有限公司 Bifidobacterium, application thereof and food composition containing same
CN106929494B (en) 2009-12-09 2021-05-14 诺维信公司 Methods of producing GH8 xylanase variants
CN102703369B (en) * 2012-05-30 2013-11-06 邓启文 Recombinant bifidobacterium for preparing EV (Enterovirus) 71 vaccine as well as preparation method and application of recombinant bifidobacterium
JP6470967B2 (en) * 2014-12-25 2019-02-13 花王株式会社 Mutant xylanase
CN104651337B (en) * 2015-01-28 2017-11-03 浙江大学 A kind of zytase, its encoding gene xyn lxy and its application
US20210244777A1 (en) 2017-12-08 2021-08-12 Morinaga Milk Industry Co., Ltd. Novel bifidobacterium bacteria and composition including novel bifidobacterium bacteria
WO2019112054A1 (en) 2017-12-08 2019-06-13 森永乳業株式会社 Novel bifidobacterium bacteria and composition including novel bifidobacterium bacteria

Also Published As

Publication number Publication date
EP3949760A4 (en) 2023-06-07
KR20210146295A (en) 2021-12-03
AU2020251432A1 (en) 2021-11-11
JP7528057B2 (en) 2024-08-05
CN113613511A (en) 2021-11-05
CA3133958A1 (en) 2020-10-08
EP3949760A1 (en) 2022-02-09
BR112021019330A2 (en) 2021-12-07
JPWO2020203782A1 (en) 2020-10-08
US20220160795A1 (en) 2022-05-26
TW202103583A (en) 2021-02-01
WO2020203782A1 (en) 2020-10-08
MX2021011930A (en) 2021-11-03

Similar Documents

Publication Publication Date Title
PH12016501953A1 (en) Pediatric nutritional composition with human milk oligosaccharides, prebiotics and probiotics
LT3600364T (en) Compositions comprising a bacterial strain of the genus megasphaera and uses thereof
SG11202109817VA (en) Novel bifidobacterium genus bacterium having high capacity to utilize polysaccharides of dietary origin
PL2173196T3 (en) Use of probiotics and fibers for diarrhoea
EP3725321A4 (en) Composition containing bacterium belonging to genus bifidobacterium as active ingredient
MX2016014807A (en) Alpha (1,2) fucosyltransferase syngenes for use in the production of fucosylated oligosaccharides.
MX2015013157A (en) Carbohydrate compositions.
AU2019263623A8 (en) Probiotic Bifidobacterium breve strain and compositions comprising said strain
MX2017007654A (en) Probiotic strains having cholesterol absorbing capacity, methods and uses thereof.
MX2022000369A (en) Bifidobacterium bifidum bacterial strain, the compositions thereof and related uses.
PH12016500271A1 (en) Probiotic for infantile excessive crying
MX2015000338A (en) Novel strain of lactobacillus crispatus.
PH12014502811A1 (en) Dietary management of celiac disease and food allergy
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
MX2013007737A (en) Fiber and probiotics for reducing intestinal symptoms related to stress.
SG11202113250VA (en) Production of fucosylated oligosaccharides in bacillus
SG11201803121WA (en) Nutritional compositions comprising lactobacillus rhamnosus gg, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate
MX2013007735A (en) Fiber and probiotics for reducing intestinal symptoms related to chronic stress.
BR112017023636A2 (en) dietary supplement
WO2018230960A3 (en) Novel bifidobacterium bifidum strain and strain-derived polysaccharide
MX2022001534A (en) Fermented plant-based probiotic compositions and processes of preparing the same.
MX2015010694A (en) Functional peptides for obesity disorders.
EP3604497A4 (en) Novel bifidobacterium genus bacterium
MX2019008292A (en) Probiotic compositions and uses thereof.
PH22017000839U1 (en) Composition of seaweed (eucheuma sp) mango jam